SickKids Enters a New Era
SickKids next step is a big leap. We are front and centre on the global stage for paediatric health so as scientific advancements and discoveries are made we have the opportunity to improve and adapt. How are we driving change?
BREAKTHROUGHS IN RESEARCH: Groundbreaking research is our best weapon in the fight against disease and congenital childhood conditions.
Meet Dr. Salter, Chief of Research at SickKids
SickKids Chief of Research Dr. Michael Salter is optimistic about the future. He recently established a five-year strategic plan for the Institute with an emphasis on innovation, integration and translation of new knowledge. He believes a key differentiator of our research enterprise is our increasing integration of research and clinical care. We are making groundbreaking discoveries about fundamental aspects of biology and translating these discoveries into new ways of understanding disease and into novel therapies that will transform child health.
Thanks to the breadth and depth of our Research Institute, ranging from the study of molecules right up to population health, we are a world leader in paediatric research. Salter believes our greatest opportunity to advance child health in the coming years is through applying genetic breakthroughs to all areas of health research, creating a paradigm shift in how we view and treat illness.
Unlocking the genetic map of each patient and gaining insight into how variation affects the whole will allow us to develop precise, novel therapies to treat each individual. We will no longer look at a patient as having ‘cancer’ but rather as an individual afflicted with a rare disease, and we will develop therapies to address their specific needs. From rare genetic diseases, to cancer, to cystic fibrosis, with genome sequencing, gene editing and individualized drug development, we are at a crossroads to breaking through with research.